Quantcast

Latest Cynosure Inc. Stories

2014-09-10 08:30:22

WESTFORD, Mass., Sept. 10, 2014 /PRNewswire/ -- Cynosure, Inc. (NASDAQ: CYNO), a leader in laser- and light-based aesthetic treatments for non-invasive and minimally invasive applications, today announced the promotion of Chris Aronson to Vice President of North American Sales. Aronson, previously Cynosure's Eastern Area Director of Sales, will be responsible for managing the Company's North American direct distribution channel and expanding customer relationships throughout the...

2014-09-08 08:29:43

Deal Complements Cynosure's Platform with Radiofrequency Energy Sources and Accessory Products for Aesthetic and Surgical Indications; WESTFORD, Mass., Sept. 8, 2014 /PRNewswire/ -- Cynosure, Inc. (NASDAQ: CYNO), a leader in laser- and light-based aesthetic treatments for non-invasive and minimally invasive applications, today announced that it has acquired the assets of Ellman International, Inc. for approximately $13.2 million in cash. In addition, Cynosure assumed certain...

2014-07-30 08:33:38

WESTFORD, Mass., July 30, 2014 /PRNewswire/ -- Cynosure, Inc. (NASDAQ: CYNO), a leader in laser- and light-based aesthetic treatments for non-invasive and minimally invasive applications, today announced that the Board of Directors has promoted Executive Vice President, Chief Operating Officer and Chief Financial Officer Timothy W. Baker to President of the Company, effective August 1, 2014. Baker, 53, will continue to serve as CFO and will take the title of President from Michael...

2014-07-29 16:25:56

The World's Most Advanced Laser Technology for Tattoo Removal and Benign Pigmented Lesions Is Now FDA-Cleared To Treat Acne Scars WESTFORD, Mass., July 29, 2014 /PRNewswire/ -- With acne as the most common skin condition affecting more than 60 million Americans today, it is no surprise that 20 million people have severe enough acne to cause scarring (33 percent of sufferers). Cynosure, the leader in aesthetic lasers, announced today that PicoSure is the first and only picosecond laser now...

2014-07-29 08:32:19

WESTFORD, Mass., July 29, 2014 /PRNewswire/ -- Cynosure, Inc. (Nasdaq: CYNO), which develops and markets laser- and light-based aesthetic treatment systems for high-volume applications, today reported financial results for the three months ended June 30, 2014. Second-quarter 2014 financial results incorporate the acquisition of Palomar Medical Technologies, which was completed on June 24, 2013. Second-Quarter 2014 Financial Highlights -- Total revenues increased 45% to $72.6 million...

2014-07-24 08:34:26

Demonstrates Ability of FOCUS Lens Array Technology to Treat Additional High-Volume Indications WESTFORD, Mass., July 24, 2014 /PRNewswire/ -- Cynosure, Inc. (NASDAQ: CYNO), a leader in laser- and light-based aesthetic treatments for non-invasive and minimally invasive applications, today announced that it has received FDA 510(k) clearance to market its flagship PicoSure(TM) Picosecond Laser Workstation for the treatment of acne scars with the FOCUS lens array, the Company's new...

2014-07-16 08:28:40

WESTFORD, Mass., July 16, 2014 /PRNewswire/ -- Cynosure, Inc. (Nasdaq: CYNO), which develops and markets laser- and light-based aesthetic treatment systems for high-volume applications, today announced that the Company will release its second-quarter 2014 financial results before the market opens on Tuesday, July 29 and host a conference call for investors and analysts that day at 9:00 a.m. ET. On the call, Chairman, Chief Executive Officer and President Michael Davin and Executive...

2014-05-19 12:30:54

LONDON, May 19, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Anti-aging Market (Anti-wrinkle products, Hair Color, Hair restoration treatment, Breast augmentation and Radio frequency devices) -Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 -...

2014-05-06 08:34:38

Board of Directors Increases Share Repurchase Program to $35 Million WESTFORD, Mass., May 6, 2014 /PRNewswire/ -- Cynosure, Inc. (Nasdaq: CYNO), which develops and markets laser- and light-based aesthetic treatment systems for high-volume applications, today reported financial results for the three months ended March 31, 2014. First-quarter 2014 financial results incorporate the acquisition of Palomar Medical Technologies, which was completed in June 2013. First-Quarter 2014 Financial...

2014-04-22 08:33:42

WESTFORD, Mass., April 22, 2014 /PRNewswire/ -- Cynosure, Inc. (Nasdaq: CYNO), which develops and markets laser- and light-based aesthetic treatment systems for high-volume applications, today announced that the company will release its first-quarter 2014 financial results before the market opens on Tuesday, May 6 and host a conference call for investors and analysts that day at 9:00 a.m. ET. On the call, Chairman, Chief Executive Officer and President Michael Davin and Executive...


Word of the Day
jument
  • A beast of burden; also, a beast in general.
'Jument' ultimately comes from the Latin 'jugum,' yoke.
Related